Efficacy of oral JAK inhibitors for atopic dermatitis: a systematic review and meta-analysis
收藏官方服务：
资源简介：
Supplemental materials
补充材料
应用场景：
创建时间：
2024-01-31
相关数据集
Table8_Anti-inflammatory and immunomodulatory effects of polysaccharide extracted from Wuguchong (maggot) on 2,4-dinitrochlorobenzene-induced atopic dermatitis in mice.XLSX
Atopic dermatitis (AD) is an inflammatory, heterogeneous, chronic skin disorder characterized by recurrent eczematous lesions and intense pruritus, and the pathophysiology mechanism of AD is known for
NIAID Data Ecosystem180
Oral JAK Inhibitors in the Management of Nail Psoriasis: An Evidence Based Review
Nail psoriasis is a manifestation of psoriasis localized to the nails, often presenting with pitting, onycholysis, and subungual hyperkeratosis. Currently, there are no FDA approved treatments specifi
Mendeley Data50
Skin microbiome in atopic dermatitis after apple cider vinegar soaks
Atopic dermatitis is an extremely common allergic skin disease, characterized by altered cutaneous immunity and skin barrier defects that increase susceptibility to recurrent bacterial skin infections
NIAID Data Ecosystem30
Table_3_The efficacy and safety of IL-13 inhibitors in atopic dermatitis: A systematic review and meta-analysis.docx
BackgroundSeveral clinical trials have evaluated the efficacy and safety of interleukin-13 (IL-13) with lebrikizumab and tralokinumab in patients with moderate to severe atopic dermatitis (AD). Howeve
NIAID Data Ecosystem60
Full-text articles assessed for eligibility.
Background The newly approved biologics and Janus kinase inhibitors (JAKi) for pediatric atopic dermatitis (AD) offer additional options for clinical treatment. However, the efficacy and safety differ
NIAID Data Ecosystem50
